Drug intelligence / Profile preview

beta-hydroxy-beta-methylbutyrate + adenosine triphosphate

Development stage
Preclinical
Lead developer
TSI Group
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination dietary supplement** of **beta-hydroxy-beta-methylbutyrate (HMB)**, a metabolite of leucine, and **adenosine triphosphate (ATP)**, the primary energy carrier molecule in cells. HMB is commonly used to **support muscle health** by stimulating muscle protein synthesis (primarily via mTOR pathway activation [1][3][4]) and inhibiting muscle protein breakdown, including via ubiquitin-proteasome and autophagic-lysosomal systems[1]. ATP supplementation may enhance muscle performance and training adaptations by directly supporting muscle energy availability[2]. In clinical studies, this **combination has shown additive and synergistic effects**, leading to **increased lean body mass, strength, and power in trained individuals**, particularly during periods of high physical stress or overreaching[2]. Effects on recovery, reduced muscle damage, improved aerobic and anaerobic capacity, and attenuation of strength decline under fatigue have also been observed[2][4]. The combination is not classified as a pharmaceutical, but rather as a sports nutrition product.

Other names
HMB + ATPbeta-hydroxy-beta-methylbutyrate and adenosine triphosphateHMB-FA + ATPHMB free acid + ATP
02

Targets

Autophagy (Autophagy machinery (ATG family))Mechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on beta-hydroxy-beta-methylbutyrate + adenosine triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-hydroxy-beta-methylbutyrate + adenosine triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call